Latest filing published 16 Jun 2022 for Cue Biopharma, Inc., €158k.
Insider track record
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
Cameron Gray: trading record in brief
All filings by Cameron Gray on record concern Cue Biopharma, Inc., in the capacity of board member. The record holds 4 filings, for trades running from 29 September 2020 to 14 June 2022.
Every open-market trade on record is a purchase: 2 purchases worth €129k, and no sale. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. Other entries cover 2 share grants.
Most recently, on 16 June 2022, the filings show a share grant worth €158k in Cue Biopharma, Inc. The last purchase on record was published on 1 October 2020, which is 2,230 days ago. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. The legal deadline for a Form 4 is two business days after the transaction. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to Cameron Gray
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 61,111 shares@ US$2.70100.0% of flowCommon StockSEC:0001209191-22-037394:0
1 of 1 declaration
